Finance

Beta
Lists
096760:KRX
JW Holdings Corp
â‚©3,775.00
+1.75%
(+65.00) 1D
Jun 11, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 096760...
Open
â‚©3,710
High
â‚©3,850
Low
â‚©3,660
Mkt. cap
279.07B
Avg. vol.
108.58K
Volume
66.23K
Dividend
5.70%
Quarterly dividend
â‚©54
Ex-dividend date
Mar 31, 2026
P/E ratio
3.79
52-wk high
â‚©4,495
52-wk low
â‚©3,145
EPS
â‚©995
Shares outstanding
73.92M
No. of employees
128
Open
â‚©3,710
High
â‚©3,850
Low
â‚©3,660
Mkt. cap
279.07B
Avg. vol.
108.58K
Volume
66.23K
Dividend
5.70%
Quarterly dividend
â‚©54
Ex-dividend date
Mar 31, 2026
P/E ratio
3.79
52-wk high
â‚©4,495
52-wk low
â‚©3,145
EPS
â‚©995
Shares outstanding
73.92M
No. of employees
128
News stories
From sources across the web
About JW Holdings Corp
CEO-
Employees128
Founded1945
Headquarters-
SectorPharmaceutical industry
Websitejw-holdings.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
228.38B
244.09B
257.56B
243.22B
Cost of goods sold
108.03B
121.52B
126.68B
113.45B
Cost of revenue
108.03B
121.52B
126.68B
113.45B
Research and development expenses
13.25B
7.89B
16.72B
10.52B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.26B
63.39B
62.70B
62.30B
Operating expense
79.32B
75.41B
97.13B
78.29B
Total operating expenses
187.36B
196.93B
223.81B
191.74B
Operating income
41.03B
47.16B
33.75B
51.48B
Other non operating income
-11.42B
-7.65B
16.65B
84.34M
EBT including unusual items
29.61B
39.51B
36.98B
51.57B
EBT excluding unusual items
29.61B
39.51B
32.73B
51.57B
Income tax expense
19.48B
-961.33M
1.53B
11.77B
Effective tax rate
65.80%
-2.43%
4.15%
22.82%
Other operating expenses
973.44M
1.40B
3.68B
1.24B
Net income
4.01B
21.61B
22.75B
20.67B
Net profit margin
1.76%
8.85%
8.83%
8.50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
3.31B
-
Interest expense
-
-
-19.86B
-
Net interest expenses
-
-
-16.55B
-
Depreciation and amortization charges
3.06B
3.07B
2.91B
3.05B
EBITDA
51.86B
57.80B
45.55B
62.69B
Gain or loss from assets sale
-43.62M
-144.28M
156.44M
-10.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer